Cadence Biomedical, Inc. — Form D/A

Cadence Biomedical, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2013-02-28. The offering totals $1.6M, of which $1.3M was reported sold. Industry: Other.

Offering

• Filed: 2013-02-28
• Form: D/A
• Accession: 0001533465-13-000004
• Industry: Other
• Exemptions: 06
• Total offering: $1.6M
• Amount sold: $1.3M
• Remaining: $314K
• Investors: 48
• Date of first sale: 2011-12-27
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-171049

Issuer

• Name: Cadence Biomedical, Inc.
• CIK: 0001533465
• Entity type: Corporation
• Jurisdiction: WASHINGTON
• Incorporated: 2007
• Address: 3534 BAGLEY AVENUE N, SEATTLE, WA, 98103
• Phone: 206-659-0614

Officers, directors & promoters (15)

Other filings by this issuer (5)

More

• CIK 1533465 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search